CI&T , a global technology transformation specialist and fast-growing public company, announces today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with ...

Earlier this week, the European Commission followed the advice of its human medicines advisory committee, the CHMP, and revoked ... remains valid until further notice. In a statement, Advanz ...

Eli Lilly, which is seeking European approval of Kisunla for the treatment of early symptomatic Alzheimer's, said it will seek re-examination by CHMP. The Indianapolis drugmaker said it remains ...

A federal appeals panel on Friday halted the reinstatement of two independent agency members fired by President Trump, ...

Eisai (ESAIY) and Biogen (BIIB) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has reaffirmed its positive opinion by consensus for ...

The CHMP has specifically backed Leqembi to treat mild cognitive impairment or mild dementia from Alzheimer’s but only for patients carrying one or no copy of the ApoE4 gene.

In January 2025, as part of its decision-making process, the EC asked the CHMP to consider information on the safety of lecanemab that became available after the adoption of the CHMP opinion in ...

The CHMP’s positive opinion includes support for administration of VYJUVEK in either a health care setting (e.g., a clinic) or at home. If deemed appropriate by a healthcare professional ...

The commission last month asked the CHMP to consider whether the new information would require an update of the positive opinion, and to consider whether the wording of the risk minimization ...

The New York Stock Exchange provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update?for market insights before trading begins.  Kristen Scholer ...